This inventor holds 3 USPTO granted patents. Top assignees: Istituto Di Ricerche Biologia Molecolare P. Angeletti Spa, Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa, Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.p.a.. Active years: 2010-2011.
Company Filing History:
1 out of 1 
1 out of 47 
1 out of 8 Years Active: 2010-2011
Title: Caterina Ercolani: Innovator in Antiviral Research
Introduction
Caterina Ercolani is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of antiviral research, particularly in the development of compounds targeting the hepatitis C virus (HCV). With a total of 3 patents, her work has the potential to impact the treatment and prevention of viral infections.
Latest Patents
Caterina's latest patents include innovative compounds that serve as modulators of HCV replication. The first patent focuses on compounds of formula (I), which can act as modulators of viral replication and/or virus production, specifically targeting the hepatitis C virus. The second patent involves tetracyclic indole derivatives, which are described as antiviral agents. This invention relates to tetracyclic indole compounds of formula (I) and their use in pharmaceutical compositions for the treatment or prevention of HCV infections.
Career Highlights
Throughout her career, Caterina has worked with esteemed organizations such as the Istituto di Ricerche di Biologia Molecolare P. Angeletti S.p.a. and the Istituto di Ricerche Biologia Molecolare P. Angeletti Spa. Her research has been pivotal in advancing the understanding of antiviral mechanisms and developing new therapeutic strategies.
Collaborations
Caterina has collaborated with notable professionals in her field, including Ian Stansfield and Frank Narjes. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Caterina Ercolani stands out as a dedicated inventor in the realm of antiviral research. Her contributions, particularly in the fight against hepatitis C, highlight her commitment to advancing medical science. Her work continues to inspire future innovations in the field.